sozobraincenter.com

NUROSYM

Pioneering Non-Invasive Treatment Through Vagus Nerve Rewiring

NUROSYM

Redefining Therapy with Advanced Vagal Neuromodulation

Nurosym is at the forefront of a new technology class that utilizes bioelectrical signals to target neural circuits of organs, offering a way to treat diseases without surgery or medication.

It rewires your nervous system by delivering small, targeted electrical impulses to the brain via the Vagus Nerve, triggering specific therapeutic mechanisms to counteract nervous system dysregulation and significantly improve health outcomes. It utilizes advanced neuromodulation technology in a sleek, easy-to-use wearable device and has been validated by leading research institutions through randomized placebo-controlled clinical trials.

Nurosym is a certified medical device and the most extensively studied non-invasive vagal neuromodulation system in the world.

Have you been diagnosed with any of the following conditions?

  • Anxiety and Stress related conditions
  • Chronic Fatigue Syndrome (CFS)/ Myalgic encephalomyelitis (ME) / Brain fog
  • Irritable Bowel Syndrome (IBS)
  • Sleep problems
  • Depressive thoughts
  • Inflammatory conditions
  • Memory & Attention problems
  • Dysautonomia
  • Postural Orthostatic Tachycardia Syndrome (POTS)
  • Tinnitus
  • Fibromyalgia
  • Heart Failure

 

These conditions and syndromes are associated with autonomic nervous system imbalance and vagus nerve impairment. Recent research indicates that Nurosym can also enhance learning, short-term memory, and cognitive function.

Nurosym has been proven to promote relaxation, improve mood and sleep, support healthy digestion, increase heart rate variability (HRV), and reduce symptoms of stress, burnout, and adrenal fatigue. Ongoing research is exploring the effects of neuromodulation on athletic performance, muscle recovery, obesity, alcoholism, and more.

Talk to our medical team and see how Nurosym can help with your condition.

NUROSYM

FAQs


Nurosym is not recommended for patients who have undergone surgery to cut the vagus nerve, have been diagnosed with severe bradycardia, patients with a permanent implanted metallic or electronic device and pregnant women.

Nurosym is among the few registered neuromodulation-based medical devices with safety confirmed by regulatory bodies in the EU through randomized placebo-controlled studies. It has received a CE Mark in the EU and has been granted FDA Non-Significant Risk Designation, both affirming the device's safety.

Many devices on the market claim to offer benefits when used in conjunction with practices like meditation or breathing exercises, which independently contribute to relaxation, anxiety reduction, mood improvement, stress relief, and better sleep.

The placebo effect can significantly influence the perceived benefits of many devices. Only randomized placebo-controlled clinical studies can determine if a device's benefits are independent of the placebo effect. Nurosym has shown benefits independent of other factors in several randomized placebo-controlled studies.